Parmax Pharma posts Q1 FY 23 loss at Rs. 1.31 Cr

Parmax Pharma posts Q1 FY 23 loss at Rs. 1.31 Cr

By: IPP Bureau

Last updated : August 14, 2022 10:24 am



The company has reported total income of Rs. 1.56 crores during the period ended June 30, 2022


Parmax Pharma Ltd has posted net loss of Rs. 1.31 crores for the period ended June 30, 2022 as against net loss of Rs. 0.04 crores for the period ended March 31, 2022. The company posted net loss of Rs. 0.43 crores for the period ended June 30, 2021.

The company has reported total income of Rs. 1.56 crores during the period ended June 30, 2022 as compared to Rs. 7.10 crores during the period ended March 31, 2022. It reported total income of Rs.1.75 crores during the period ended June 30, 2021.

Parmax Pharma Ltd

First Published : August 14, 2022 12:00 am